Literature DB >> 8836040

Heparan sulfate: a piece of information.

M Salmivirta1, K Lidholt, U Lindahl.   

Abstract

The sulfated glycosaminoglycans, heparan sulfate and heparin, are increasingly implicated in cell-biological processes such as cytokine action, cell adhesion, and regulation of enzymic catalysis. These activities generally depend on interactions of the polysaccharides with proteins, mediated by distinct saccharide sequences, and expressed at various levels of specificity, selectivity, and molecular organization. The formation of heparin/ heparan sulfate in the cell requires an elaborate biosynthetic machinery, that is conceived in terms of a novel model of glycosaminoglycan assembly and processive modification. Recent advances in the identification and molecular analysis of the enzymes and other proteins involved in the biosynthesis provide novel tools to study the regulation of the process, presently poorly understood, at the subcellular and cellular levels. The potential medical importance of heparin-related compounds is likely to promote the biotechnological exploitation of components of the biosynthetic machinery.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836040     DOI: 10.1096/fasebj.10.11.8836040

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  88 in total

1.  Enzyme interactions in heparan sulfate biosynthesis: uronosyl 5-epimerase and 2-O-sulfotransferase interact in vivo.

Authors:  M A Pinhal; B Smith; S Olson; J Aikawa; K Kimata; J D Esko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

2.  Intact aggrecan and fragments generated by both aggrecanse and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury.

Authors:  M L Lemons; J D Sandy; D K Anderson; D R Howland
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

Review 3.  The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins.

Authors:  G Duncan; C McCormick; F Tufaro
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

4.  Specific interaction of the envelope glycoproteins E1 and E2 with liver heparan sulfate involved in the tissue tropismatic infection by hepatitis C virus.

Authors:  Fumi Kobayashi; Shuhei Yamada; Shuhei Taguwa; Chikako Kataoka; Satomi Naito; Yoshiki Hama; Hideki Tani; Yoshiharu Matsuura; Kazuyuki Sugahara
Journal:  Glycoconj J       Date:  2012-06-03       Impact factor: 2.916

Review 5.  Intracellular proteoglycans.

Authors:  Svein Olav Kolset; Kristian Prydz; Gunnar Pejler
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

6.  Lcl of Legionella pneumophila is an immunogenic GAG binding adhesin that promotes interactions with lung epithelial cells and plays a crucial role in biofilm formation.

Authors:  Carla Duncan; Akriti Prashar; Jannice So; Patrick Tang; Donald E Low; Mauricio Terebiznik; Cyril Guyard
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

Review 7.  In vitro methods in the study of viral and prion permeability across the blood-brain barrier.

Authors:  Ryota Nakaoke; William A Banks
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

8.  Involvement of chondroitin sulfate synthase-3 (chondroitin synthase-2) in chondroitin polymerization through its interaction with chondroitin synthase-1 or chondroitin-polymerizing factor.

Authors:  Tomomi Izumikawa; Toru Uyama; Yuka Okuura; Kazuyuki Sugahara; Hiroshi Kitagawa
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

9.  Electron detachment dissociation of glycosaminoglycan tetrasaccharides.

Authors:  Jeremy J Wolff; I Jonathan Amster; Lianli Chi; Robert J Linhardt
Journal:  J Am Soc Mass Spectrom       Date:  2006-10-30       Impact factor: 3.109

10.  Heparin inhibits IFN-gamma-induced fractalkine/CX3CL1 expression in human endothelial cells.

Authors:  Masaharu Hatakeyama; Tadaatsu Imaizumi; Wakako Tamo; Koji Yamashita; Hidemi Yoshida; Ikuo Fukuda; Kei Satoh
Journal:  Inflammation       Date:  2004-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.